Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

9.73
Delayed Data
As of Mar 29
 +0.43 / +4.62%
Today’s Change
8.61
Today|||52-Week Range
15.45
-6.35%
Year-to-Date
No recent news for Avadel Pharmaceuticals PLC.

Today’s Trading

Previous close9.30
Today’s open9.37
Day’s range9.37 - 9.98
Volume55,383
Average volume (3 months)104,120
Market cap$402.6M
Dividend yield--
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)-200.25%
Earnings growth (this year)+446.67%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-13.04%
P/E ratio16.2
Price/Sales2.86
Price/Book9.52

Competitors

 Today’s
change
Today’s
% change
AQXPAquinox Pharmaceutic...+0.68+4.16%
MACKMerrimack Pharmaceut...+0.03+1.00%
ADMSAdamas Pharmaceutica...+0.04+0.23%
CNCEConcert Pharmaceutic...+0.16+0.93%
Data as of 03/29/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$149.8M
Annual profit (last year)-$41.2M
Net profit margin-27.47%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Michael Shannon Anderson
CFO, Treasurer, Director &
CAO
Michael F. Kanan
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs